Iberoamerican Journal of Medicine
Iberoamerican Journal of Medicine
Clinical Image

Pulmonary thromboembolism in an anticoagulated oncological patient

Tromboembolismo pulmonary en un paciente oncológico anticoagulado

Diana Alegre-González, Ramón Baeza-Trinidad, Leticia de Ávila-Lizarraga, Laura Fernández-Prado

Downloads: 0
Views: 534


Thromboembolic disease; Chemoteraphy; Cisplatin

Palabras clave

Enfermedad tromboembólica; Quimioterapia; Cisplatino


1. Nasser NJ, Fox J, Agbarya A. Potential Mechanisms of Cancer-Related Hypercoagulability. Cancers (Basel). 2020;12(3):566. doi: 10.3390/cancers12030566.
2. Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013;119(3):648-55. doi: 10.1002/cncr.27772.
3. Seng S, Liu Z, Chiu SK, Proverbs-Singh T, Sonpavde G, Choueiri TK, et al. Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. J Clin Oncol. 2012;30(35):4416-26. doi: 10.1200/JCO.2012.42.4358.
4. Nadeau Nguyen MC, Woronow D, Binks B, Nayernama A, Jones SC. Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System. JACC CardioOncol. 2021;3(1):165. doi: 10.1016/j.jaccao.2020.11.017.
5. Sato N, Mishima T, Okubo Y, Okamoto T, Shiraishi S, Tsuchida M. Acute aortic thrombosis in the ascending aorta after cisplatin-based chemotherapy for esophageal cancer: a case report. Surg Case Rep. 2022;8(1):75. doi: 10.1186/s40792-022-01431-8.

Submitted date:

Reviewed date:

Accepted date:

Publication date:

64dbf550a953955ecc395074 iberoamericanjm Articles
Links & Downloads

Iberoam J Med

Share this page
Page Sections